page contents

Johnson & Johnson: Another Day, Another Bullish Analyst

Yet another analyst has declared that shares of Johnson & Jonson (JNJ) can still climb higher even after posting 19% gains since the start of the year.

It was back in April when my colleague Ben Levisohn said that the selloff in J&J shares that followed the healthcare conglomerate’s first quarter revenue miss was a buying opportunity,…
Stocks to Watch

Leave a Reply

Your email address will not be published. Required fields are marked *

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close